drugset / Trial / NCT04469998
Evaluation of AXR-270 for the Treatment of Posterior Blepharitis Associated With Meibomian Gland Dysfunction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the safety, tolerability and efficacy of AXR-270 Cream in treating posterior blepharitis associated with Meibomian Gland Disease (MGD)
Timeline
- Start
- 2020-06-16
- Primary completion
- 2020-12-01
- Completion
- 2020-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AXR-270 | Unknown | — | Topical |